Summit Biosciences Overview
- Year Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
99

- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
Summit Biosciences General Information
Description
Developer of a specialized pharmaceutical platform designed to focus on developing, manufacturing, and commercializing generic and innovative nasal spray medicines. The company's platform offers unit-dose, nasal spray products with the development of pre-filled, disposable, intranasal spray products, enabling clients to address and meet important needs for the management of chronic and acute care conditions.
Contact Information
Website
www.summitbiosciences.comCorporate Office
- UK Coldstream Research Campus
- 1513 Bull Lea Road
- Lexington, KY 40511
- United States
Corporate Office
- UK Coldstream Research Campus
- 1513 Bull Lea Road
- Lexington, KY 40511
- United States
Summit Biosciences Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Summit Biosciences Comparisons
Industry
Financing
Details

Summit Biosciences Competitors (4)
One of Summit Biosciences’s 4 competitors is ARS Pharmaceuticals, a Corporation company based in San Diego, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ARS Pharmaceuticals | Corporation | San Diego, CA | ||||
Tioga Pharmaceuticals | Venture Capital-Backed | San Diego, CA | ||||
Orasis Pharmaceuticals | Venture Capital-Backed | Ponte Vedra Beach, FL | ||||
Xlear | Corporation | American Fork, UT |
Summit Biosciences Patents
Summit Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220387421-A1 | Drug products for intranasal administration and uses thereof | Inactive | 05-Feb-2020 | ||
AU-2021217164-A1 | Drug products for intranasal administration and uses thereof | Pending | 05-Feb-2020 | ||
CA-3166250-A1 | Drug products for intranasal administration and uses thereof | Pending | 05-Feb-2020 | ||
EP-4100012-A1 | Drug products for intranasal administration and uses thereof | Pending | 05-Feb-2020 | ||
US-20240226093-A1 | Drug products for intranasal administration and uses thereof | Pending | 05-Feb-2020 | A61K31/485 |
Summit Biosciences Signals
Summit Biosciences Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Summit Biosciences FAQs
-
When was Summit Biosciences founded?
Summit Biosciences was founded in 2009.
-
Where is Summit Biosciences headquartered?
Summit Biosciences is headquartered in Lexington, KY.
-
What is the size of Summit Biosciences?
Summit Biosciences has 99 total employees.
-
What industry is Summit Biosciences in?
Summit Biosciences’s primary industry is Drug Discovery.
-
Is Summit Biosciences a private or public company?
Summit Biosciences is a Private company.
-
What is Summit Biosciences’s current revenue?
The current revenue for Summit Biosciences is
. -
How much funding has Summit Biosciences raised over time?
Summit Biosciences has raised $3.2M.
-
Who are Summit Biosciences’s investors?
Kentucky Cabinet for Economic Development, Kentucky Innovation Network, Keyhorse Capital, and Yearling Management have invested in Summit Biosciences.
-
Who are Summit Biosciences’s competitors?
ARS Pharmaceuticals, Tioga Pharmaceuticals, Orasis Pharmaceuticals, and Xlear are competitors of Summit Biosciences.
-
When was Summit Biosciences acquired?
Summit Biosciences was acquired on 18-Jan-2024.
-
Who acquired Summit Biosciences?
Summit Biosciences was acquired by Kindeva Drug Delivery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »